Arthneeti

Prolife Industries Q2 FY27 Share Price & Earnings Call Analysis

₹79.80+5.00% today
Market cap
₹33 Cr
P/E
7.69
ROE
8.94%
PEG
-0.51
Price to sales
0.60
Debt to equity
0.01
52W high / low
₹181 / ₹56.0
Sales growth (5Y)
-5.84%
EBITDA margin
7.54%
Net profit margin
7.81%
Promoter holding
73.74%
Sales (last year)
₹54 Cr

Incorporated in 1994, Prolife Industries Ltd manufactures intermediates for dyes, pigments, pharmaceuticals, agrochemicals, etc.[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Prolife Industries rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹1,858 Cr25.8
240%+Up 0–2%₹234 Cr3.0
340%+Flat₹3,514 Cr4.3
440%+Flat₹2,257 Cr30.0
540%+Flat₹180 Cr11.9
640%+Flat₹138 Cr15.1

Sign up free to see every company in the sector ranking and track Prolife Industries.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Prolife Industries

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Prolife Industries

Shareholding breakup across reporting periods.

Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Promoters +73.74%73.74%73.74%73.74%73.74%73.74%73.74%73.74%73.74%73.74%73.74%73.74%
Public +26.26%26.26%26.26%26.26%26.26%26.26%26.26%26.26%26.26%26.26%26.26%26.26%
No. of Shareholders142131130148148382446458477487473459

Financials of Prolife Industries

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of Prolife Industries

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +19.5822.1927.1427.2029.5850.3873.5073.0878.1556.8155.3554.4056.66
Sales growth+3.32%+13.33%+22.31%+0.22%+8.75%+70.32%+45.89%-0.57%+6.94%-27.31%-2.57%-1.72%-1.53%
Expenses +17.7620.3924.6023.6525.3844.8265.2867.1069.4145.0049.6750.3051.75
Operating Profit1.821.802.543.554.205.568.225.988.7411.815.684.104.91
OPM %9.30%8.11%9.36%13.05%14.20%11.04%11.18%8.18%11.18%20.79%10.26%7.54%8.67%
Other Income +0.310.450.100.270.461.780.621.632.181.592.082.842.51
Interest1.111.010.840.840.910.630.520.480.430.330.340.090.00
Depreciation0.400.420.470.890.931.030.931.161.251.211.100.980.87
Profit before tax0.620.821.332.092.825.687.395.979.2411.866.325.876.55
Tax %37.10%35.37%33.83%28.23%28.01%28.87%25.58%27.97%25.11%26.14%25.79%27.43%
Net Profit +0.400.530.871.502.044.045.504.306.918.764.684.254.76
EPS in Rs1.331.772.133.664.989.8713.4310.5016.8821.4011.4310.3811.63
Dividend Payout %8.94%7.03%9.40%6.82%6.01%3.04%2.23%2.85%1.78%2.33%26.22%2.89%

Financials of Prolife Industries

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital1.491.494.094.094.094.094.094.094.094.094.094.094.09
Reserves1.532.104.596.008.0311.9217.3021.4828.2736.9041.3845.5147.50
Borrowings +10.108.615.074.827.157.715.494.711.923.812.580.270.27
Other Liabilities +4.573.844.776.227.4211.9421.7525.156.887.125.274.5215.83
Total Liabilities17.6916.0418.5221.1326.6935.6648.6355.4341.1651.9253.3254.3967.69
Fixed Assets +2.733.218.119.5610.049.609.3411.4311.3611.2910.5110.227.50
CWIP0.130.570.530.000.000.000.000.000.000.000.000.000.00
Investments2.872.811.521.771.761.221.221.221.211.211.211.213.56
Other Assets +11.969.458.369.8014.8924.8438.0742.7828.5939.4241.6042.9656.63
Total Assets17.6916.0418.5221.1326.6935.6648.6355.4341.1651.9253.3254.3967.69

Financials of Prolife Industries

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +0.024.15-0.085.840.8110.025.113.730.0517.33-1.25-1.64
Cash from Investing Activity +-0.17-1.41-3.28-3.27-2.33-4.69-5.64-3.051.463.49-1.182.66
Cash from Financing Activity +0.47-2.863.30-1.861.63-3.74-1.31-0.14-1.43-0.72-1.69-2.32
Net Cash Flow0.33-0.13-0.060.710.101.58-1.840.540.0820.11-4.12-1.31
Free Cash Flow-0.822.82-2.904.04-0.599.434.440.48-1.0816.18-1.57-2.56
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit15%249%17%180%38%210%85%91%27%173%7%-1%

Financials of Prolife Industries

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days62.6463.6657.5638.11100.4452.1678.4683.7649.5534.4455.7971.93
Inventory Days170.7769.1643.0365.1737.0562.5952.3276.7939.4063.6868.3996.46
Days Payable91.3968.7371.78104.12104.5589.97124.33149.8925.9937.7130.1821.16
Cash Conversion Cycle142.0264.0828.81-0.8432.9324.786.4510.6662.9660.4194.00147.23
Working Capital Days87.6140.4654.0618.1254.910.078.9419.5857.5428.9870.10109.90
ROCE %13.70%14.93%16.57%20.31%21.83%29.03%30.83%22.57%29.96%30.83%14.35%12.17%

Continue your research

What Prolife Industries's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Unilex Colour &C (Q2 FY27)

    685.02 lakhs (Consolidated) with a YoY increase of approximately 2.22% (Rs. Key results statement takeaways from Unilex Colour & Chemical Ltd's Q2 FY27 results

  • Andhra Sugars (Q2 FY27)

    3,276.52 lakhs (~5.5% increase) . Key results statement takeaways from Andhra Sugars Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Shanti Inorganics (Q2 FY27)

    54.02 crore (Rs. Key results statement takeaways from Shanti Inorganics Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Renol Polychem (Q2 FY27)

    Revenue from Operations (Consolidated) for the half year ended 30.09.2026: ₹5,684.60 lakhs; for 30.09.2025: ₹4,006.43 lakhs. Key results statement takeaways fro

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF